Compare · GEHC vs PHG
GEHC vs PHG
Side-by-side comparison of GE HealthCare Technologies Inc. (GEHC) and Koninklijke Philips N.V. NY Registry Shares (PHG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GEHC and PHG operate in Medical Electronics (Health Care), so they compete in similar markets.
- GEHC is the larger of the two at $27.76B, about 1.1x PHG ($24.89B).
- GEHC has been more active in the news (14 items in the past 4 weeks vs 3 for PHG).
- GEHC has more recent analyst coverage (25 ratings vs 22 for PHG).
- Company
- GE HealthCare Technologies Inc.
- Koninklijke Philips N.V. NY Registry Shares
- Price
- $61.01+0.33%
- $26.16-0.70%
- Market cap
- $27.76B
- $24.89B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 14
- 3
- Recent ratings
- 25
- 22
Koninklijke Philips N.V. NY Registry Shares
Koninklijke Philips N.V. operates as a health technology company in North America, Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides magnetic resonance imaging, computed tomography, advanced molecular imaging, diagnostic X-ray, and imaging components as well as integrated clinical solutions; integrated interventional systems, including interventional diagnostic and therapeutic devices; imaging products focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. The company also offers monitoring and analytics solutions; sleep and respiratory care solutions; emergency care and resuscitation, and patient management solutions; data, analytics, and actionable workflow solutions; and connected care informatics solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; male grooming and beauty products and solutions; and kitchen appliances, home care, and garment care products, as well as coffee machines. Koninklijke Philips N.V. has a partnership with openDoctor to deliver an integrated radiology patient engagement platform that leverages openDoctor's real-time online appointment scheduling services as part of its patient management solution; and a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Latest GEHC
- Chief Financial Officer Saccaro James bought $200,585 worth of shares (3,310 units at $60.60), increasing direct ownership by 4% to 87,471 units (SEC Form 4)
- GC & Corporate Secretary Jimenez Frank R bought $105,788 worth of shares (1,750 units at $60.45), increasing direct ownership by 2% to 93,932 units (SEC Form 4)
- President and CEO Arduini Peter J bought $249,827 worth of shares (4,169 units at $59.92), increasing direct ownership by 2% to 259,424 units (SEC Form 4)
- GE HealthCare downgraded by Goldman with a new price target
- SEC Form 10-Q filed by GE HealthCare Technologies Inc.
- GE HealthCare Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GE HealthCare reports first quarter 2026 financial results
- GE HealthCare announces executive team and operational updates to enhance execution, accelerate innovation, and drive growth
- GE HealthCare management to present at upcoming investor conferences
- GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents
Latest PHG
- Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction
- Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning
- Philips receives FDA 510(k) clearance for Verida, the world's first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications
- SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares
- SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares
- FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair
- Philips launches IntraSight Plus to simplify coronary interventions and advance precision care
- Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant
- Philips convenes the Annual General Meeting of Shareholders 2026
- Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment